載入...
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis
BACKGROUND AND AIMS: In literature systematic data on treatment with the fixed-dose combination of sofosbuvir and velpatasvir for 12 weeks in anti-HCV/HCV RNA positive subjects with mild fibrosis and naïve to previous Interferon free regimen are scanty. A meta-analysis has been performed to evaluate...
Na minha lista:
| 發表在: | Acta Biomed |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mattioli 1885
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776220/ https://ncbi.nlm.nih.gov/pubmed/31124995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v90i2.8374 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|